StonvexLoading…
StonvexCore line items from RGTI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-10 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $5.15M | $4.40M | $7.09M | $5.22M | $3.27M |
Operating Income | Not available | $-25.95M | $-84.66M | $-62.06M | $-41.51M |
Net Income | Not available | $33.11M | $-216.21M | $-198.00M | $2.96M |
EPS (Diluted) | $-0.05 | $-0.06 | $-0.70 | $-0.65 | $0.00 |
Total Assets | Not available | $650.68M | $666.57M | $630.27M | $636.69M |
Total Liabilities | Not available | $67.09M | $120.38M | $258.45M | $83.43M |
Cash & Equivalents | Not available | $48.15M | $44.85M | $26.13M | $57.18M |
Free Cash Flow OCF − CapEx | Not available | $-20.63M | $-77.22M | $-57.74M | $-38.03M |
Shares Outstanding | Not available | 332.31M | 331.28M | 325.31M | 323.76M |